Sign inGet started

KRSA

Korsana Biosciences, Inc.CIK 1755237 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
5

AI insights for KRSA PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for KRSA
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Pernice Michelle PatriciaDirector2$0$02026-09-09
Gottesdiener AndrewDirector2$0$02026-09-09
Fairmount Funds Management LLCDirector, 10% Owner1$0$02026-09-09
Shah Nimish PDirector2$0$02026-09-09
Harwin Peter EvanDirector, 10% Owner1$0$02026-09-09

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Gottesdiener AndrewDirector A Award deriv2026-09-092026-09-1048,445— $048,445SEC↗
Harwin Peter EvanDirector, 10% Owner A Award deriv2026-09-092026-09-1048,445— $048,445SEC↗
Shah Nimish PDirector A Award deriv2026-09-092026-09-1048,445— $048,445SEC↗
Pernice Michelle PatriciaDirector A Award deriv2026-09-092026-09-1048,445— $048,445SEC↗
Pernice Michelle PatriciaDirector A Award deriv2026-09-092026-09-1048,445— $048,445SEC↗
Shah Nimish PDirector A Award deriv2026-09-092026-09-1048,445— $048,445SEC↗
Gottesdiener AndrewDirector A Award deriv2026-09-092026-09-1048,445— $048,445SEC↗
Fairmount Funds Management LLCDirector, 10% Owner A Award deriv2026-09-092026-09-1048,445— $048,445SEC↗